GeneReach Biotechnology Corp. (4171.TWO)
TWD 19.0
(-7.54%)
TWD 19.0
(-7.54%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.17 Billion TWD | -27.48% |
| 2022 | 1.62 Billion TWD | -3.71% |
| 2021 | 1.68 Billion TWD | 35.78% |
| 2020 | 1.24 Billion TWD | 63.04% |
| 2019 | 760.86 Million TWD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 1.18 Billion TWD | -0.18% |
| 2024 Q1 | 1.18 Billion TWD | 1.04% |
| 2023 FY | 1.17 Billion TWD | -27.48% |
| 2023 Q1 | 1.53 Billion TWD | -5.6% |
| 2023 Q4 | 1.17 Billion TWD | -2.67% |
| 2023 Q3 | 1.2 Billion TWD | -18.08% |
| 2023 Q2 | 1.47 Billion TWD | -3.66% |
| 2022 Q4 | 1.62 Billion TWD | 0.0% |
| 2022 FY | 1.62 Billion TWD | -3.71% |
| 2021 FY | 1.68 Billion TWD | 35.78% |
| 2020 FY | 1.24 Billion TWD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 2.9 Billion TWD | 59.456% |
| Level Biotechnology Inc. | 822.67 Million TWD | -42.966% |
| Sagittarius Life Science Corp | 664.72 Million TWD | -76.937% |
| NeoCore Technology Co., Ltd. | 548.74 Million TWD | -114.332% |
| TaiMed Biologics Inc. | 3.89 Billion TWD | 69.795% |
| GlycoNex Incorporation | 1.55 Billion TWD | 24.257% |
| VBI | 452.1 Million TWD | -160.15% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 748.57 Million TWD | -57.118% |
| Visgeneer Inc. | 397.17 Million TWD | -196.126% |
| Mycenax Biotech Inc. | 3.77 Billion TWD | 68.806% |
| Sunmax Biotechnology Co., Ltd. | 2.15 Billion TWD | 45.525% |
| G&E Herbal Biotechnology Co., Ltd. | 883.09 Million TWD | -33.184% |
| Medigen Vaccine Biologics Corporation | 6.09 Billion TWD | 80.696% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 73.55 Million TWD | -1498.931% |
| Enimmune corporation | 604.82 Million TWD | -94.459% |
| TaiRx, Inc. | 833.74 Million TWD | -41.067% |
| CHO Pharma, Inc. | 3.08 Billion TWD | 61.888% |
| EirGenix Inc. | 11.16 Billion TWD | 89.464% |
| BioLASCO Taiwan Co., Ltd. | 573.13 Million TWD | -105.211% |
| Sunny Pharmtech Inc. | 1.71 Billion TWD | 31.315% |
| Lin BioScience, Inc. | 3.59 Billion TWD | 67.3% |
| BioGend Therapeutics Co., Ltd. | 1.05 Billion TWD | -11.962% |
| Feng Chi Biotech Corp. | 301.03 Million TWD | -290.703% |
| Bio Preventive Medicine Corp. | 264.65 Million TWD | -344.402% |
| Lukas Biomedical Inc. | 441.19 Million TWD | -166.583% |
| RBC Bioscience Corporation | 753.79 Million TWD | -56.03% |
| BiOptic Inc. | 613.77 Million TWD | -91.625% |
| BRIM Biotechnology, Inc. | 1.77 Billion TWD | 33.875% |
| Shine-On BioMedical Co.,Ltd. | 1.15 Billion TWD | -1.416% |
| Great Novel Therapeutics Biotech & Medicals | 644.84 Million TWD | -82.39% |
| Syngen Biotech Co.,Ltd. | 3.1 Billion TWD | 62.136% |
| Anti-Microbial Savior BioteQ Co., Ltd | 128.04 Million TWD | -818.524% |
| SynCore Biotechnology Co.,Ltd | 378.36 Million TWD | -210.851% |
| Genomics BioSci & Tech. Co.,Ltd. | 1.13 Billion TWD | -3.73% |
| Neith Corporation | 192.15 Million TWD | -512.086% |
| Advagene Biopharma Co., Ltd. | 147.93 Million TWD | -695.045% |
| NaviFUS Corp. | 490.53 Million TWD | -139.767% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 1.22 Billion TWD | 4.044% |
| Sinew Pharma Inc. | 1.36 Billion TWD | 13.733% |
| Andros Pharmaceuticals Co.,Ltd | 529.14 Million TWD | -122.272% |
| Greenyn Biotechnology Co., Ltd | 1.16 Billion TWD | -1.27% |
| Lumosa Therapeutics Co., Ltd. | 1.65 Billion TWD | 28.989% |
| AP Biosciences Inc | 890.75 Million TWD | -32.039% |
| Medigen Biotechnology Corp. | 8.52 Billion TWD | 86.207% |
| 3D Global Biotech Inc. | 324.14 Million TWD | -262.841% |
| Pharmosa Biopharm Inc. | 1.33 Billion TWD | 11.81% |
| Intech Biopharm Corporation | 2.71 Billion TWD | 56.617% |
| Oneness Biotech Co., Ltd. | 15.36 Billion TWD | 92.345% |
| Eusol Biotech Co.,Ltd. | 410.25 Million TWD | -186.684% |
| TWi Biotechnology, Inc. | 396.85 Million TWD | -196.369% |
| Ever Supreme Bio Technology Co., Ltd | 2.07 Billion TWD | 43.344% |
| TCI GENE Inc. | 1.16 Billion TWD | -0.875% |
| MegaPro Biomedical Co., Ltd | 294.58 Million TWD | -299.259% |
| Senhwa Biosciences, Inc. | 1.36 Billion TWD | 13.73% |
| Taiwan Bio Therapeutics Co., Ltd | 941.76 Million TWD | -24.888% |
| NatureWise Biotech & Medicals Corporation | 698.45 Million TWD | -68.393% |
| PharmaEngine, Inc. | 3.95 Billion TWD | 70.254% |
| Savior Lifetec Corporation | 3.82 Billion TWD | 69.232% |
| TaiGen Biopharmaceuticals Holdings Limited | 1.22 Billion TWD | 4.366% |
| OBI Pharma, Inc. | 5.6 Billion TWD | 79.012% |
| Meribank Biotech Co., Ltd | 1.06 Billion TWD | -10.747% |
| Acepodia, Inc. | 6.81 Billion TWD | 82.751% |
| Caliway Biopharmaceuticals Co., Ltd. | 3.82 Billion TWD | 69.263% |